Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - DELCATH SYSTEMS, INC. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 14, 2011 (April 13, 2011)
DELCATH SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
001-16133
|
06-1245881
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification Number)
|
810 Seventh Avenue, Suite 3505, New York, New York, 10019
(Address of principal executive offices, including zip code)
(212) 489-2100
(Registrant’s telephone number, including area code)
NONE
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01. Other Events.
On April 13, 2011, Delcath Systems, Inc. issued a press release announcing that it has received notice of CE Mark approval for its proprietary Hepatic CHEMOSATTM Delivery System. Receipt of the CE Mark allows Delcath to market and sell the product in countries in the European Economic Area. A copy of the press release is filed as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
The following exhibit is filed herewith:
|
(d)
|
Exhibits.
|
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press Release of Delcath Systems, Inc., dated April 13, 2011
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
DELCATH SYSTEMS, INC.
|
||||
|
Dated: April 14, 2011
|
By:
|
/s/ Peter Graham
|
||
|
Name:
|
Peter Graham
|
|||
|
Title:
|
Executive Vice President & General Counsel
|
|||
EXHIBIT INDEX
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press Release of Delcath Systems, Inc., dated April 13, 2011
|